ID   SUCB1_HUMAN             Reviewed;         463 AA.
AC   Q9P2R7; B2RDE7; O95194; Q5T9Q4; Q5T9Q6; Q9NV21; Q9NVP7;
DT   27-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2006, sequence version 3.
DT   10-MAY-2017, entry version 177.
DE   RecName: Full=Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03220};
DE            EC=6.2.1.5 {ECO:0000255|HAMAP-Rule:MF_03220, ECO:0000269|PubMed:15877282};
DE   AltName: Full=ATP-specific succinyl-CoA synthetase subunit beta {ECO:0000255|HAMAP-Rule:MF_03220};
DE            Short=A-SCS {ECO:0000255|HAMAP-Rule:MF_03220};
DE   AltName: Full=Succinyl-CoA synthetase beta-A chain {ECO:0000255|HAMAP-Rule:MF_03220};
DE            Short=SCS-betaA {ECO:0000255|HAMAP-Rule:MF_03220};
DE   Flags: Precursor;
GN   Name=SUCLA2 {ECO:0000255|HAMAP-Rule:MF_03220};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10727444; DOI=10.1172/JCI6816;
RA   Furuyama K., Shigeru S.;
RT   "Interaction between succinyl CoA synthetase and the heme-biosynthetic
RT   enzyme ALAS-E is disrupted in sideroblastic anemia.";
RL   J. Clin. Invest. 105:757-764(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   THR-199.
RC   TISSUE=Placenta, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-199.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 38-463 (ISOFORM 1), TISSUE SPECIFICITY,
RP   AND VARIANT THR-199.
RC   TISSUE=Liver;
RX   PubMed=9765291; DOI=10.1074/jbc.273.42.27580;
RA   Johnson J.D., Mehus J.G., Tews K., Milavetz B.I., Lambeth D.O.;
RT   "Genetic evidence for the expression of ATP- and GTP-specific
RT   succinyl-CoA synthetases in multicellular eucaryotes.";
RL   J. Biol. Chem. 273:27580-27586(1998).
RN   [7]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [8]
RP   INTERACTION WITH ALAS2.
RX   PubMed=14643893; DOI=10.1016/S1357-2725(03)00246-2;
RA   Cox T.C., Sadlon T.J., Schwarz Q.P., Matthews C.S., Wise P.D.,
RA   Cox L.L., Bottomley S.S., May B.K.;
RT   "The major splice variant of human 5-aminolevulinate synthase-2
RT   contributes significantly to erythroid heme biosynthesis.";
RL   Int. J. Biochem. Cell Biol. 36:281-295(2004).
RN   [9]
RP   INVOLVEMENT IN MTDPS5, CATALYTIC ACTIVITY, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15877282; DOI=10.1086/430843;
RA   Elpeleg O., Miller C., Hershkovitz E., Bitner-Glindzicz M.,
RA   Bondi-Rubinstein G., Rahman S., Pagnamenta A., Eshhar S., Saada A.;
RT   "Deficiency of the ADP-forming succinyl-CoA synthase activity is
RT   associated with encephalomyopathy and mitochondrial DNA depletion.";
RL   Am. J. Hum. Genet. 76:1081-1086(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-84, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [11]
RP   INVOLVEMENT IN MTDPS5, AND SUBCELLULAR LOCATION.
RX   PubMed=17287286; DOI=10.1093/brain/awl383;
RA   Ostergaard E., Hansen F.J., Sorensen N., Duno M., Vissing J.,
RA   Larsen P.L., Faeroe O., Thorgrimsson S., Wibrand F., Christensen E.,
RA   Schwartz M.;
RT   "Mitochondrial encephalomyopathy with elevated methylmalonic acid is
RT   caused by SUCLA2 mutations.";
RL   Brain 130:853-861(2007).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-78 AND LYS-143, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   SUBCELLULAR LOCATION, CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE
RP   ANALYSIS] AFTER ASN-52, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   VARIANTS MTDPS5 ARG-118 AND CYS-284.
RX   PubMed=17301081; DOI=10.1093/brain/awl389;
RA   Carrozzo R., Dionisi-Vici C., Steuerwald U., Lucioli S., Deodato F.,
RA   Di Giandomenico S., Bertini E., Franke B., Kluijtmans L.A.,
RA   Meschini M.C., Rizzo C., Piemonte F., Rodenburg R., Santer R.,
RA   Santorelli F.M., van Rooij A., Vermunt-de Koning D., Morava E.,
RA   Wevers R.A.;
RT   "SUCLA2 mutations are associated with mild methylmalonic aciduria,
RT   Leigh-like encephalomyopathy, dystonia and deafness.";
RL   Brain 130:862-874(2007).
RN   [17]
RP   VARIANT MTDPS5 ASN-251.
RX   PubMed=23759946; DOI=10.1038/jhg.2013.45;
RA   Jaberi E., Chitsazian F., Ali Shahidi G., Rohani M., Sina F.,
RA   Safari I., Malakouti Nejad M., Houshmand M., Klotzle B., Elahi E.;
RT   "The novel mutation p.Asp251Asn in the beta-subunit of succinate-CoA
RT   ligase causes encephalomyopathy and elevated succinylcarnitine.";
RL   J. Hum. Genet. 58:526-530(2013).
CC   -!- FUNCTION: ATP-specific succinyl-CoA synthetase functions in the
CC       citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA
CC       to the synthesis of ATP and thus represents the only step of
CC       substrate-level phosphorylation in the TCA (PubMed:15877282). The
CC       beta subunit provides nucleotide specificity of the enzyme and
CC       binds the substrate succinate, while the binding sites for
CC       coenzyme A and phosphate are found in the alpha subunit (By
CC       similarity). {ECO:0000255|HAMAP-Rule:MF_03220,
CC       ECO:0000269|PubMed:15877282}.
CC   -!- CATALYTIC ACTIVITY: ATP + succinate + CoA = ADP + phosphate +
CC       succinyl-CoA. {ECO:0000255|HAMAP-Rule:MF_03220,
CC       ECO:0000269|PubMed:15877282}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03220};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_03220};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle;
CC       succinate from succinyl-CoA (ligase route): step 1/1.
CC       {ECO:0000255|HAMAP-Rule:MF_03220, ECO:0000305|PubMed:15877282}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The beta
CC       subunit determines specificity for ATP (By similarity). Interacts
CC       with ALAS2 (PubMed:14643893). {ECO:0000255|HAMAP-Rule:MF_03220,
CC       ECO:0000269|PubMed:14643893}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000255|HAMAP-
CC       Rule:MF_03220, ECO:0000269|PubMed:15877282,
CC       ECO:0000269|PubMed:17287286, ECO:0000269|PubMed:25944712}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9P2R7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P2R7-2; Sequence=VSP_006292;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Not expressed in liver and
CC       lung. {ECO:0000269|PubMed:9765291}.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 5 (MTDPS5)
CC       [MIM:612073]: A disorder due to mitochondrial dysfunction. It is
CC       characterized by infantile onset of hypotonia, neurologic
CC       deterioration, a hyperkinetic-dystonic movement disorder, external
CC       ophthalmoplegia, deafness, variable renal tubular dysfunction, and
CC       mild methylmalonic aciduria in some patients.
CC       {ECO:0000269|PubMed:15877282, ECO:0000269|PubMed:17287286,
CC       ECO:0000269|PubMed:17301081, ECO:0000269|PubMed:23759946}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the succinate/malate CoA ligase beta
CC       subunit family. ATP-specific subunit beta subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03220}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB035863; BAA92873.1; -; mRNA.
DR   EMBL; AK001458; BAA91703.1; -; mRNA.
DR   EMBL; AK001847; BAA91939.1; -; mRNA.
DR   EMBL; AK315513; BAG37894.1; -; mRNA.
DR   EMBL; AL157369; CAI15149.1; -; Genomic_DNA.
DR   EMBL; AL157369; CAI15153.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08777.1; -; Genomic_DNA.
DR   EMBL; BC027587; AAH27587.1; -; mRNA.
DR   EMBL; AF058953; AAC64396.1; -; mRNA.
DR   CCDS; CCDS9406.1; -. [Q9P2R7-1]
DR   RefSeq; NP_003841.1; NM_003850.2. [Q9P2R7-1]
DR   UniGene; Hs.743361; -.
DR   ProteinModelPortal; Q9P2R7; -.
DR   SMR; Q9P2R7; -.
DR   BioGrid; 114331; 52.
DR   IntAct; Q9P2R7; 16.
DR   MINT; MINT-3078782; -.
DR   STRING; 9606.ENSP00000367923; -.
DR   DrugBank; DB00139; Succinic acid.
DR   iPTMnet; Q9P2R7; -.
DR   PhosphoSitePlus; Q9P2R7; -.
DR   SwissPalm; Q9P2R7; -.
DR   BioMuta; SUCLA2; -.
DR   DMDM; 94730427; -.
DR   EPD; Q9P2R7; -.
DR   MaxQB; Q9P2R7; -.
DR   PaxDb; Q9P2R7; -.
DR   PeptideAtlas; Q9P2R7; -.
DR   PRIDE; Q9P2R7; -.
DR   Ensembl; ENST00000378654; ENSP00000367923; ENSG00000136143. [Q9P2R7-1]
DR   GeneID; 8803; -.
DR   KEGG; hsa:8803; -.
DR   UCSC; uc001vbs.3; human. [Q9P2R7-1]
DR   CTD; 8803; -.
DR   DisGeNET; 8803; -.
DR   GeneCards; SUCLA2; -.
DR   GeneReviews; SUCLA2; -.
DR   HGNC; HGNC:11448; SUCLA2.
DR   HPA; HPA039435; -.
DR   HPA; HPA039536; -.
DR   HPA; HPA061528; -.
DR   MalaCards; SUCLA2; -.
DR   MIM; 603921; gene.
DR   MIM; 612073; phenotype.
DR   neXtProt; NX_Q9P2R7; -.
DR   OpenTargets; ENSG00000136143; -.
DR   Orphanet; 1933; Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria.
DR   PharmGKB; PA36245; -.
DR   eggNOG; KOG2799; Eukaryota.
DR   eggNOG; COG0045; LUCA.
DR   GeneTree; ENSGT00390000010170; -.
DR   HOVERGEN; HBG055555; -.
DR   InParanoid; Q9P2R7; -.
DR   KO; K01900; -.
DR   OMA; YIESGCD; -.
DR   OrthoDB; EOG091G07T9; -.
DR   PhylomeDB; Q9P2R7; -.
DR   TreeFam; TF300624; -.
DR   BioCyc; MetaCyc:ENSG00000136143-MONOMER; -.
DR   BRENDA; 6.2.1.5; 2681.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   UniPathway; UPA00223; UER00999.
DR   ChiTaRS; SUCLA2; human.
DR   GeneWiki; SUCLA2; -.
DR   GenomeRNAi; 8803; -.
DR   PRO; PR:Q9P2R7; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000136143; -.
DR   CleanEx; HS_SUCLA2; -.
DR   ExpressionAtlas; Q9P2R7; baseline and differential.
DR   Genevisible; Q9P2R7; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004775; F:succinate-CoA ligase (ADP-forming) activity; TAS:UniProtKB.
DR   GO; GO:0006105; P:succinate metabolic process; IEA:Ensembl.
DR   GO; GO:0006104; P:succinyl-CoA metabolic process; TAS:ProtInc.
DR   GO; GO:0006781; P:succinyl-CoA pathway; NAS:UniProtKB.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome.
DR   Gene3D; 3.30.1490.20; -; 1.
DR   Gene3D; 3.40.50.261; -; 1.
DR   HAMAP; MF_00558; Succ_CoA_beta; 1.
DR   HAMAP; MF_03220; Succ_CoA_betaA_euk; 1.
DR   InterPro; IPR011761; ATP-grasp.
DR   InterPro; IPR013650; ATP-grasp_succ-CoA_synth-type.
DR   InterPro; IPR013815; ATP_grasp_subdomain_1.
DR   InterPro; IPR005811; CoA_ligase.
DR   InterPro; IPR017866; Succ-CoA_synthase_bsu_CS.
DR   InterPro; IPR034723; Succ_CoA_betaA_euk.
DR   InterPro; IPR005809; Succ_CoA_synthase_bsu.
DR   InterPro; IPR016102; Succinyl-CoA_synth-like.
DR   PANTHER; PTHR11815; PTHR11815; 1.
DR   Pfam; PF08442; ATP-grasp_2; 1.
DR   Pfam; PF00549; Ligase_CoA; 1.
DR   PIRSF; PIRSF001554; SucCS_beta; 1.
DR   SUPFAM; SSF52210; SSF52210; 1.
DR   TIGRFAMs; TIGR01016; sucCoAbeta; 1.
DR   PROSITE; PS50975; ATP_GRASP; 1.
DR   PROSITE; PS01217; SUCCINYL_COA_LIG_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Disease mutation; Ligase; Magnesium; Metal-binding; Mitochondrion;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide; Tricarboxylic acid cycle.
FT   TRANSIT       1     52       Mitochondrion.
FT                                {ECO:0000244|PubMed:25944712}.
FT   CHAIN        53    463       Succinate--CoA ligase [ADP-forming]
FT                                subunit beta, mitochondrial.
FT                                {ECO:0000255|HAMAP-Rule:MF_03220}.
FT                                /FTId=PRO_0000033352.
FT   DOMAIN       61    288       ATP-grasp. {ECO:0000255|HAMAP-
FT                                Rule:MF_03220}.
FT   NP_BIND     105    107       ATP. {ECO:0000255|HAMAP-Rule:MF_03220}.
FT   REGION      380    382       Substrate binding; shared with subunit
FT                                alpha. {ECO:0000255|HAMAP-Rule:MF_03220}.
FT   METAL       258    258       Magnesium. {ECO:0000255|HAMAP-
FT                                Rule:MF_03220}.
FT   METAL       272    272       Magnesium. {ECO:0000255|HAMAP-
FT                                Rule:MF_03220}.
FT   BINDING      98     98       ATP. {ECO:0000255|HAMAP-Rule:MF_03220}.
FT   BINDING     323    323       Substrate; shared with subunit alpha.
FT                                {ECO:0000255|HAMAP-Rule:MF_03220}.
FT   SITE         94     94       Important for substrate specificity.
FT                                {ECO:0000255|HAMAP-Rule:MF_03220}.
FT   SITE        162    162       Important for substrate specificity.
FT                                {ECO:0000255|HAMAP-Rule:MF_03220}.
FT   MOD_RES      78     78       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      84     84       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES      88     88       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9Z2I9}.
FT   MOD_RES      88     88       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9Z2I9}.
FT   MOD_RES     129    129       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9Z2I9}.
FT   MOD_RES     139    139       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9Z2I9}.
FT   MOD_RES     143    143       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     216    216       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9Z2I9}.
FT   MOD_RES     279    279       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z2I9}.
FT   MOD_RES     341    341       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9Z2I9}.
FT   MOD_RES     368    368       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9Z2I9}.
FT   VAR_SEQ      26     47       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_006292.
FT   VARIANT      13     13       V -> M (in dbSNP:rs35201084).
FT                                /FTId=VAR_046214.
FT   VARIANT     118    118       G -> R (in MTDPS5; dbSNP:rs121908537).
FT                                {ECO:0000269|PubMed:17301081}.
FT                                /FTId=VAR_046215.
FT   VARIANT     199    199       S -> T (in dbSNP:rs7320366).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:9765291,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_013459.
FT   VARIANT     251    251       D -> N (in MTDPS5; dbSNP:rs397515462).
FT                                {ECO:0000269|PubMed:23759946}.
FT                                /FTId=VAR_070123.
FT   VARIANT     284    284       R -> C (in MTDPS5; dbSNP:rs121908538).
FT                                {ECO:0000269|PubMed:17301081}.
FT                                /FTId=VAR_046216.
FT   CONFLICT     40     40       N -> D (in Ref. 2; BAA91939).
FT                                {ECO:0000305}.
FT   CONFLICT    203    203       I -> V (in Ref. 2; BAA91939).
FT                                {ECO:0000305}.
FT   CONFLICT    323    323       N -> S (in Ref. 2; BAA91703).
FT                                {ECO:0000305}.
SQ   SEQUENCE   463 AA;  50317 MW;  1E1651728AF3B5CD CRC64;
     MAASMFYGRL VAVATLRNHR PRTAQRAAAQ VLGSSGLFNN HGLQVQQQQQ RNLSLHEYMS
     MELLQEAGVS VPKGYVAKSP DEAYAIAKKL GSKDVVIKAQ VLAGGRGKGT FESGLKGGVK
     IVFSPEEAKA VSSQMIGKKL FTKQTGEKGR ICNQVLVCER KYPRREYYFA ITMERSFQGP
     VLIGSSHGGV NIEDVAAESP EAIIKEPIDI EEGIKKEQAL QLAQKMGFPP NIVESAAENM
     VKLYSLFLKY DATMIEINPM VEDSDGAVLC MDAKINFDSN SAYRQKKIFD LQDWTQEDER
     DKDAAKANLN YIGLDGNIGC LVNGAGLAMA TMDIIKLHGG TPANFLDVGG GATVHQVTEA
     FKLITSDKKV LAILVNIFGG IMRCDVIAQG IVMAVKDLEI KIPVVVRLQG TRVDDAKALI
     ADSGLKILAC DDLDEAARMV VKLSEIVTLA KQAHVDVKFQ LPI
//
